The role of the human gut microbiota in colonization and infection with multidrug-resistant bacteria

• Main Authors: Irene Wuethrich, Benedikt W. Pelzer, Yascha Khodamoradi, Maria J. G. T. Vehreschild
• Format: Article
• Language: English
• Published: Taylor & Francis Group 2021-01-01
• Series: Gut Microbes
• Subjects: microbiota; multidrug resistance; bacterial infection; dysbiosis; microbial therapy
• Online Access: http://dx.doi.org/10.1080/19490976.2021.1911279

About 100 years ago, the first antibiotic drug was introduced into health care. Since then, antibiotics have made an outstanding impact on human medicine. However, our society increasingly suffers from collateral damage exerted by these highly effective drugs. The rise of resistant pathogen strains, combined with a reduction of microbiota diversity upon antibiotic treatment, has become a significant obstacle in the fight against invasive infections worldwide. Alternative and complementary strategies to classical “Fleming antibiotics” comprise microbiota-based treatments such as fecal microbiota transfer and administration of probiotics, live-biotherapeutics, prebiotics, and postbiotics. Other promising interventions, whose efficacy may also be influenced by the human microbiota, are phages and vaccines. They will facilitate antimicrobial stewardship, to date the only globally applied antibiotic resistance mitigation strategy. In this review, we present the available evidence on these nontraditional interventions, highlight their interaction with the human microbiota, and discuss their clinical applicability.